Whole body physiologically-based pharmacokinetic models: their use in clinical drug development

Author： Edginton Andrea N Theil Frank-Peter Schmitt Walter Willmann Stefan

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.4, Iss.9, 2008-09, pp. : 1143-1152

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Linking preclinical and clinical whole-body physiologically based pharmacokinetic models with prior distributions in NONMEM

By Langdon Grant Gueorguieva Ivelina Aarons Leon Karlsson Mats

European Journal of Clinical Pharmacology, Vol. 63, Iss. 5, 2007-05 ,pp. : 485-498

Springer Publishing Company

Access to resources Recommend Favorite

A Physiologically-Based Pharmacokinetic Model of Drug Detoxification by Nanoparticles

By Fallon Marissa S. Varshney Manoj Dennis Donn M. Chauhan Anuj

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 31, Iss. 5, 2004-10 ,pp. : 381-400

Springer Publishing Company

Access to resources Recommend Favorite

Have physiologically-based pharmacokinetic models delivered?

By Edginton Andrea N Joshi Ghanashyam

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 8, 2011-08 ,pp. : 929-934

Informa Healthcare

Access to resources Recommend Favorite

Integration of Physiologically‐Based Pharmacokinetic Modeling into Early Clinical Development: An Investigation of the Pharmacokinetic Nonlinearity

Cpt: Pharmacometrics & Systems Pharmacology, Vol. 4, Iss. 5, 2015-05 ,pp. : 286-294

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prediction of drug‐drug interactions using physiologically‐based pharmacokinetic models of CYP450 modulators included in Simcyp software

Biopharmaceutics And Drug Disposition, Vol. 39, Iss. 1, 2018-01 ,pp. : 3-17

John Wiley & Sons Inc

Access to resources Recommend Favorite